HC Bars Cipla, 3 others from launching generic version of Bristol-Myers ’ drug

Delhi High Court has granted an injunction restraining the domestic pharma companies such as Cipla, Torrent, Emcure, Alkem from selling a medicine used for prevention and treatment of thromboembolic diseases, the patent for which is held by Bristol-Myers Squibb (BMS) as it filed its claims for patent infringement of Apixaban in Delhi HC.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news